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Abstract
Yersinia outer protein J (YopJ) is a type III secretion system (T3SS) effector of pathogenic Yersinia (Yersinia pestis, Yersinia
enterocolitica and Yersinia pseudotuberculosis) that is secreted into host cells. YopJ inhibits survival response pathways in
macrophages, causing cell death. Allelic variation of YopJ is responsible for differential cytotoxicity in Yersinia strains. YopJ
isoforms in Y. enterocolitica O:8 (YopP) and Y. pestis KIM (YopJ
KIM) strains have high cytotoxic activity. In addition, YopJ
KIM-
induced macrophage death is associated with caspase-1 activation and interleukin-1b (IL-1b secretion. Here, the mechanism
of YopJ
KIM-induced cell death, caspase-1 activation, and IL-1b secretion in primary murine macrophages was examined.
Caspase-3/7 activity was low and the caspase-3 substrate poly (ADP-ribose) polymerase (PARP) was not cleaved in Y. pestis
KIM5-infected macrophages. In addition, cytotoxicity and IL-1b secretion were not reduced in the presence of a caspase-8
inhibitor, or in B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax)/Bcl-2 homologous antagonist/killer (Bak) knockout
macrophages, showing that YopJ
KIM-mediated cell death and caspase-1 activation occur independent of mitochondrial-
directed apoptosis. KIM5-infected macrophages released high mobility group protein B1 (HMGB1), a marker of necrosis, and
microscopic analysis revealed that necrotic cells contained active caspase-1, indicating that caspase-1 activation is
associated with necrosis. Inhibitor studies showed that receptor interacting protein 1 (RIP1) kinase and reactive oxygen
species (ROS) were not required for cytotoxicity or IL-b release in KIM5-infected macrophages. IL-1b secretion was reduced
in the presence of cathepsin B inhibitors, suggesting that activation of caspase-1 requires cathepsin B activity. Ectopically-
expressed YopP caused higher cytotoxicity and secretion of IL-1b in Y. pseudotuberculosis-infected macrophages than
YopJ
KIM. Wild-type and congenic caspase 1 knockout C57BL/6 mice were equally susceptible to lethal infection with Y.
pseudotuberculosis ectopically expressing YopP. These data suggest that YopJ-induced caspase-1 activation in Yersinia-
infected macrophages is a downstream consequence of necrotic cell death and is dispensable for innate host resistance to a
strain with enhanced cytotoxicity.
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Introduction
Induction of host cell death is a general and a very important
outcome of pathogen infection, since cell death may facilitate
pathogen clearance by removal of infected tissues, destruction of a
pathogenic niche or up modulation of host immune responses
[1,2]. On the other hand, some pathogens subvert host immune
responses by killing immune cells [3,4]. Not only the death of the
infected cells impacts the consequence of the battle between host
immune system and pathogens, but also the choice of cell death
pathway is important [5]. Apoptosis is characterized as having
serial apoptotic caspase activation and as non-inflammatory.
Apoptosis of immune cells such as macrophages is induced in
response to infection by many pathogens, such as Mycobacterium
tuberculosis and Y. pseudotuberculosis [6,7,8]. Unlike apoptosis,
necrosis (also called oncosis, the term necrosis will be used here)
is a form of traumatic death that results from acute cellular injury
and is independent of caspase activation. Necrotic cell death is
characterized by cell swelling, membrane rupture and release of
inflammatory contents [9,10].
A more recently characterized form of pro-inflammatory cell
death that requires caspase-1 is termed pyroptosis [9]. The
inflammasome is an intracellular sensor composed of NOD-like
receptors (NLRs) that recognizes a variety of pathogen associated
molecular patterns (PAMPs) and damage associated molecular
patterns (DAMPs) and activates caspase-1, allowing for cleavage
and secretion of cytokines such as IL-1b and IL-18 [11,12].
Inflammasomes show specificity in signal sensing: the NLR
NLRP1 (NALP1) inflammasome responds to Bacillus anthracis
lethal toxin (LT) [13]; NLR NLRC4 (IPAF) recognizes flagellin
from Salmonella enterica Typhimurium and Legionella pneumophila,
which is delivered into host cells by specialized secretion systems in
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e36019these pathogens [14,15]; and NLR NLRP3 senses a group of
structurally unrelated PAMPs and DAMPs, such as extracellular
ATP, lipoproteins, double stranded RNA, potassium (K
+) efflux,
uric acid crystals, and pore-forming toxins from Gram positive
bacteria Listeria monocytogenes and Staphylococcus aureus [16,17,18].
Pro-caspase-1 recruited by inflammasomes undergoes self-cleavage
to give rise to an active form, which processes pro-IL-1b and pro-
IL-18 to mature cytokines. Caspase-1 recruited to inflammasomes
also induces cell death, but in this case cleavage of caspase-1 may
not be required [19]. Thus, functionally distinct inflammasomes
may form in cells in response to pathogen infection [19,20].
Pyroptosis is defined as a caspase-1 dependent cell death, which
morphologically exhibits DNA fragmentation, damaged cell
membrane, and IL-18 and IL-1b release [9]. Pyroptosis occurs
in macrophages infected with Salmonella, Shigella or Fransicella
species, and can be blocked by caspase-1 inhibitor or by the use of
caspase-1 deficient cells [21,22,23]. A forth type of cell death
termed pyronecrosis has been observed in macrophages infected
with Shigella flexneri,o rNeisseria gonorrhoeae, or upon nigericin
treatment. Pyronecrosis requires the NLR NLRP3 and the
apoptosis-associated speck-like protein containing a CARD
(ASC) adaptor, but not caspase-1 [24,25,26,27,28,29]. Cell death
during pyronecrosis can be blocked with cathepsin B inhibitors,
suggesting a role for lysosome rupture [30].
Pathogenic Yersinia species (Y. enterocolitica, Y. pestis and Y.
pseudotuberculosis) encode an injectisome-like T3SS that functions to
translocate Yops into target cells [31]. Yop effector proteins
disrupt cytoskeletal and signal transduction functions in infected
immune cells to paralyze the host’s anti-bacterial responses [31].
In turn, infected host cells can sense the Yersinia T3SS as a
virulence-associated danger signal, leading to activation of
caspase-1 [32,33,34,35,36,37]. There are at least two distinct
mechanisms of caspase-1 activation in response to the Yersinia
T3SS. One mechanism requires channel or pore formation in the
host cell plasma membrane by the T3SS, and is counteracted by
several Yop effectors, including YopK [33,34,36,37]. A second
mechanism of caspase-1 activation that occurs in Yersinia-infected
macrophages requires the effector YopJ (see below).
YopJ (YopP in Y. enterocolitica) is an acetyltransferase [38,39]
activated by the host-specific factor inositol hexakisphosphate [40].
YopJ binds to mitogen-activated protein (MAP) kinase kinases
(MKKs) and inhibitor of nuclear factor kappa-B kinase beta
(IKKb) and transfers acetyl groups onto serine or threonine
residues in the active sites of these kinases [38,39]. Acetylation of
MKKs and IKKb by YopJ prevents their activation by upstream
kinases, and effectively blocks signal transduction required for
activation of MAP kinases and nuclear factor kappa B (NF-kB)
transcription factors [38,39]. As a result, YopJ activity inhibits
transcription of pro-inflammatory cytokine and cell survival genes
[41,42]. Inhibition of survival gene expression by YopJ, combined
with activation of apoptotic signaling from Toll-like receptor 4
(TLR4), results in cell death in macrophages infected with Yersinia
[43,44].
YopP-induced apoptosis in Y. enterocolitica-infected macrophages
has been studied in detail and data suggest that the death signal is
initiated from caspase-8 activation and further amplified through
mitochondria and downstream caspases [41,45]. Evidence sup-
porting this model comes from studies showing that YopP-induced
macrophage cell death is reduced by a pan-caspase inhibitor or a
caspase-8 inhibitor, that cytochrome c is released from mitochon-
dria, and that active caspase-3, -7 and -9 are detected [41,45].
Different Yersinia strains exhibit a range of cytotoxic activities on
macrophages and this heterogeneity has been linked to allelic
variation of genes encoding YopJ/YopP proteins (Table 1)
[32,35,46,47,48]. The presence of an Arg instead of a Ser at
position 143 of YopP of Y. enterocolitica O:8 strains is associated with
increased inhibition of IKKb, enhanced suppression of NF-kB
activation, and higher cytotoxicity in infected macrophages [46].
Translocation of YopP into host cells and binding to IKKb was
not affected by the polymorphism at position 143 [46]. YopJ
proteins of Y. pestis and Y. pseudotuberculosis have Arg at residue 143
but in general have lower cytotoxicity than YopP of Y. enterocolitica
O:8 due to comparatively reduced secretion and translocation into
macrophages [47,48]. Reduced secretion and translocation of
YopJ proteins is caused by polymorphisms at positions 10 and 11,
which are Ile-Ser in YopJ of Y. pestis and Y. pseudotuberculosis and
Ser-Pro in YopP of Y. enterocolitica O:8 [47]. Ectopic expression of
YopP of Y. enterocolitica O:8 in Y. pseudotuberculosis or Y. pestis results
in attenuation of these strains in mouse models of infection
[47,49], which suggests that enhanced cytotoxicity may activate an
innate host immune response to the pathogen.
Additional polymorphisms among YopJ proteins in Y. pestis and
Y. pseudotuberculosis have been identified that are responsible for
differences in macrophage cytotoxicity [32]. An isoform of YopJ
found in Y. pestis molecular group 2.MED strains such as KIM
(YopJ
KIM) have high cytotoxic activity and contain a Leu at
position 177 and a Glu at position 206 [32]. Low activity YopJ
isoforms found in other Y. pestis strains (e.g. molecular group
ORI.1 isolate CO92) have Phe at residue 177 and Lys at position
206 [32]. The YopJ isoform in Y. pseudotuberculosis has a single
change relative to YopJ
KIM, Phe at residue 177, and has
intermediate cytotoxic activity in macrophages [32]. The
increased cytotoxic activity of YopJ
KIM as compared to YopJ
CO92
could be correlated with enhanced binding to IKKb, and
enhanced inhibition of NF-kB activation [32].
Detailed studies of the features of death in host cells infected
with Yersinia strains that encode YopJ isoforms with high cytotoxic
activity have yielded evidence that pro-inflammatory modes of
destruction may be activated in addition to apoptosis. For
example, murine dendritic cells infected with Y. enterocolitica O:8
undergo YopP-dependent necrotic cell death [50]. In addition,
infection of murine macrophages with Y. pestis KIM results in
YopJ-dependent activation of caspase-1 and secretion of high
levels of IL-1b [32,35]. Human monocytes infected with KIM also
secrete high levels of IL-1b [51]. Caspase-1 is not required for
YopJ
KIM-induced cell death but is important for secretion of IL-1b
from macrophages [35]. K
+ efflux, NLRP3 and ASC were shown
to be important for IL-1b secretion in macrophages infected with
Y. pestis KIM [32]. However, the morphological features and the
mechanism of YopJ
KIM-induced macrophage death have not
Table 1. Amino acid polymorphisms that are associated with
differences in translocation or IKKb binding or inhibition
activities between different YopJ/YopP isoforms.
Amino acid position
Translocation IKKb binding or inhibition
Isoform 10 11 143 177 206
YopP
08 Ser Pro Arg Leu Glu
YopJ
KIM Ile Ser Arg Leu Glu
YopJ
YPTB Ile Ser Arg Phe Glu
YopJ
CO92 Ile Ser Arg Phe Lys
doi:10.1371/journal.pone.0036019.t001
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caspase-1 activation has not been established.
In this study, we examined the mechanism of cell death and
caspase-1 activation in macrophages infected with Y. pestis KIM.
The results suggest that YopJ
KIM induces necrotic cell death in
macrophages, which triggers a cathepsin B-dependent pathway of
caspase-1 activation. In addition, we show that macrophages
infected with Y. pseudotuberculosis ectopically expressing YopP are
efficiently killed and secrete high levels of IL-1b. However,
infection of caspase-1-deficient mice revealed that increased host
resistance to a Y. pseudotuberculosis YopP-expressing strain endowed
with enhanced cytotoxicity does not require caspase-1.
Results
Caspase-3/7 activity is low in KIM5-infected macrophages
Activation of apoptotic caspases, such as caspase-3, -7 and -9,
has been detected in macrophages undergoing YopP-dependent
cell death in response to Y. enterocolitica infection [45]. Caspase-3/7
activity assay was performed to examine apoptotic caspase
activation at 4, 8, 12 and 24 hours post-infection in macrophages
undergoing YopJ
KIM-induced cell death following infection with Y.
pestis. Murine bone marrow derived macrophages (BMDMs) were
infected at a multiplicity of infection (MOI) of 10 for 20 min. The
tissue culture media was then supplemented with gentamicin for
the remaining period of incubation to prevent growth of
extracellular bacteria [32,35]. This ‘‘low MOI’’ infection proce-
dure has previously been shown to cause cytotoxicity, activation of
caspase-1, and high level secretion of IL-1b in macrophages
[32,35]. As controls, some macrophages were left uninfected or
infected with a Y. pestis strain expressing catalytically inactive
YopJ
C172A. Caspase-3/7 activity in KIM5-infected macrophages
was higher as compared to the controls at all time points, but the
difference was not significant (Figure 1A). Lysates of macrophages
infected as in Figure 1 were subjected to immunoblotting to detect
cleavage of the caspase-3 substrate PARP. Lysates of control
macrophages treated with staurosporin, a strong inducer of
apoptosis, were analyzed in parallel. The 86 kDa cleaved PARP
(c-PARP) fragment was not detected lysates of KIM5-infected
cells, but it was seen in staurosporin-treated cell lysates (Figure 1B).
These results show that apoptotic caspases are not strongly
activated in macrophages undergoing YopJ
KIM-induced cell
death.
Apoptotic signaling through caspase-8 and mitochondria
is dispensable for KIM5-induced macrophage death
It has been shown that YopP-induced apoptosis is initiated from
caspase-8 in macrophages and dendritic cells infected with Y.
enterocolitica, and can be blocked by caspase-8 or pan-caspase
inhibitors [45,52]. A detailed study detected BH3 domain only
protein (Bid) truncation before cytochrome c release and
apoptosome activation, which suggests that the death signal
coming from caspase-8 may require mitochondria and is amplified
through caspase -3,-7 and -9 cleavage [45]. Bcl-2 family members
Bax and Bak play a central role in controlling mitochondrial-
dependent apoptosis [53]. Bax and Bak when activated create a
channel in the mitochondrial membrane, releasing cytochrome C
to activate the apoptosome. In order to test if the YopJ
KIM-
dependent death signal goes through mitochondria, we infected
Bax
2/2Bak
2/2 macrophages with KIM5, using heterozygous
Bax
+/2Bak
+/2 cells as the control. The Bax
2/2Bak
2/2 macro-
phages have been shown to be fully defective for mitochondrial-
induced apoptosis [53]. Cell death was measured by lactate
dehydrogenase (LDH) release assay and secreted IL-1b was
measured by enzyme-linked immunosorbent assay (ELISA) at
24 hr post infection. No significant differences in YopJ
KIM-





2/+ macrophages (Figure 2A and
B).
To determine if caspase-8 is required for cell death in KIM5-
infected macrophages, cells were exposed to the caspase-8
inhibitor IETD. IETD treatment did not significantly reduce
macrophage death or IL-1b secretion after 8 or 24 hours of
infection with KIM5 (Figure 3A and B). IETD treatment did
increase cytotoxicity in KIM5-infected macrophages at the
8 hours time point, but this effect was not seen at the 24 hour
time point (Figure 3A and B) or in macrophages infected with Y.
pestis expressing YopJ
C172A (Figure 3A and B). As a control, IETD
treatment was shown to effectively block cell death in macro-
phages caused by treatment with lipopolysaccharide (LPS) and the
proteasome inhibitor MG-132 (Figure 3C). Thus, apoptotic
signaling through caspase-8 and mitochondria is not required for
YopJ
KIM-induced macrophage death.
KIM5-infected macrophages exhibit necrotic features
To characterize the plasma membrane integrity of KIM5-
infected macrophages, we performed Annexin V staining/
propidium iodide (PI) uptake assay at different times (4, 8 and
12 hr post infection) and analyzed the results by fluorescence
Figure 1. Caspase-3/7 activity is low in KIM5-infected macro-
phages. (A) BMDMs were left uninfected (U) or infected with Y. pestis
strains expressing YopJ
KIM or YopJ
C172A in 96-white walled tissue culture
plates. Caspase-3/7 activity was measured 4, 8, 12 or 24 hr post-
infection with fluorometer. The results from three independent
experiments were averaged and are shown as fold change compared
to uninfected cells. Error bars represent standard deviations. Differences
in caspase-3/7 activities between uninfected and infected cells were not
significant as determined by two way ANOVA (B) BMDMs were left
uninfected (U) or infected with Y. pestis strains expressing YopJ
KIM or
YopJ
C172A or treated with 1 mM of staurosporine (STS) for 16 hr.
Macrophage lysates were collected and analyzed by PARP immuno-
blotting. Sizes of molecular weight standards (kDa) are shown on the
left. Positions of full length PARP and cleaved PARP (c-PARP) are
showed on right.
doi:10.1371/journal.pone.0036019.g001
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YopJ
C172A were analyzed in parallel as a control. As summarized
in Figure 4, two populations of cells that were either Annexin V
single positive (apoptotic) or Annexin V/PI double positive
(necrotic) were detected beginning at 8 hr post infection with
KIM5. The number of Annexin V single positive cells (,11% at
8 hr) declined slightly to 8% of total by 12 hr post infection. The
double positive population (,13% at 8 hr) increased with time to
reach 17% of total by 12 hr (Figure 4).
Release of HMGB1, a chromatin protein, can be used to
differentiate apoptosis from necrosis [54]. Immunoblotting was
used to detect HMGB1 in culture supernatants of macrophages
following 24 hr infection with KIM5 or KIM5 expressing
YopJ
C172A. As shown in Figure 5, HMGB1 was released from
macrophages infected with Y. pestis expressing YopJ
KIM but not
YopJ
C172A (lanes 3 and 4, respectively). Together, these results
suggest that a population of KIM5-infected macrophages undergo
necrosis.
KIM5-infected necrotic macrophages contain active
caspase-1
As both cell death and IL-1b release require YopJ
KIM and they
display the same trends, caspase-1 activation and cell death appear
to be related. It is possible that necrotic cell death triggers caspase-1
activation [35]. To determine if necrotic cell death and caspase-1
activation could be correlated at the single cell level, infected
macrophages were analyzed by microscopy after labeling for active
caspase-1 and PI uptake. Representative images of macrophages
infected with KIM5 or Y. pestis expressing YopJ
C172A for 9 hr are
shown in Figure 6A, and a summary of the percentages of cells that
were positive for one or both signals is shown in Figure 6B. The
percentages of KIM5-infected macrophages that were caspase-1
positive, PI positive and double positive were not significantly
different (Figure 6B), which suggests that membrane damage in
necrotic cells is associated with caspase-1 activation.
RIP1 is not required for YopJ
KIM-induced cell death or IL-
1b secretion
YopP-mediated dendritic cell death in response to Y. enterocolitica
infection is reduced by treatment with geldanamycin, a heat shock
protein 90 (Hsp90) inhibitor, which promotes RIP1 degradation
[52]. Furthermore, YopP-induced dendritic cell death is partially
independent of caspases and exhibits necrotic features [50], which
are similar to our findings with YopJ
KIM. To test if RIP1 is involved
in KIM5-induced macrophage death, we treated cells with the
specific RIP1 inhibitor necrostatin-1, which blocks necrosis in many
cell types [55]. The treated macrophages were then infected with
KIM5 or Y. pestis expressing YopJ
C172A for 8 or 24 hours.
Necrostatin-1 did not significantly reduce cell death at either time
point inKIM5-infectedmacrophages (Figure 7A). IL-1b release was
significantly reduced at 8 hr, but not at 24 hr post infection with
KIM5 (Figure 7B). From these results we conclude that RIP1 is not
required for YopJ
KIM-induced cell death or IL-1b secretion,
however it may enhance IL-1b secretion at early infection times.
ROS are not required for cytotoxicity or IL-1b secretion in
macrophages infected with KIM5
NLRP3 is important for IL-1b secretion in KIM5-infected
macrophages [32]. NLRP3 senses several structurally unrelated
PAMPs and DAMPs that share the common property of inducing
ROS [56]. It has therefore been proposed that ROS is a major
signal detected by NLRP3 [56]. The nicotinamide adenine
dinucleotide phosphate-oxidase (NADPH) inhibitor diphenyle-
neiodonium sulfate (DPI) and the radical scavenger N-acetylcys-
teine (NAC) were used to examine the importance of ROS for
cytotoxicity and IL-1b secretion in KIM5-infected macrophages.
Pretreatment of macrophages with DPI or NAC did not reduce
IL-1b release or cell death following KIM5 infection of
macrophages for 8 or 24 hr (Figure 8A and 8B). As a control,
LPS-stimulated macrophages were exposed to DPI or NAC and
NLRP3-dependent pyroptosis was induced by ATP treatment.
The amount of IL-1b released was significantly reduced by DPI
and cytotoxicity was significantly reduced by DPI and NAC
(Figure 8C and 8D). Therefore, ROS are not required for
YopJ
KIM-induced cell death or IL-1b secretion.
Inhibitors of cathepsin B reduce caspase-1 activation in
macrophages infected with KIM5
Lysosomal rupture leads to release of lysosome-localized
protease cathepsin B into the cytoplasm, which directly or
indirectly activates NLRP3/caspase-1 [57]. We examined the
lysosome rupture pathway using the cathepsin inhibitor E64d and
specific cathepsin B inhibitor CA-074-Me. Treatment of macro-
phages with either of these two inhibitors during a 24 hr KIM5
infection resulted in a significant decrease in secretion of IL-1b
(Figure 9A) but had no effect on cytotoxicity (Figure 9B).
Microscopic imaging of KIM5-infected macrophages after strain-
ing them for active caspase-1 and PI uptake showed that E64d and
CA-074-Me blocked caspase-1 activation (Figure 9C). These
results suggest that cathepsin B activity is required for YopJ
KIM-
mediated activation of caspase-1.
Figure 2. Mitochondrial-induced apoptosis is not required for
KIM5-induced macrophage death and IL-1b secretion. BMDMs
from Bax
+/2 Bak
+/2 heterozygous (BaxBak+/2) or Bax
2/2 Bak
2/2
double knockout (BaxBakDKO) C57BL/6 mice were left uninfected (U) or
infected with Y. pestis strains expressing YopJ
KIM or YopJ
C172A for 24 hr.
LDH (A) or IL-1b (B) released into supernatants were measured by
CytoTox96 assay or ELISA, respectively. Results shown are the averages
from three independent experiments. Error bars represent standard
deviations. Differences average values between BaxBak+/2 or Bax-
BakDKO conditions were not significant as determined by two way
ANOVA.
doi:10.1371/journal.pone.0036019.g002
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associated with elevated levels of IL-1b release
Higher levels of cell death are observed when dendritic cells are
infected with Y. pseudotuberculosis ectopically expressing YopP as
compared to the native isoform YopJ
YPTB [47]. Two amino acid
polymorphisms in the N-terminal region of YopP specify increased
secretion, translocation and cytotoxic activity as compared to
YopJ
YPTB (Table 1) [47]. Macrophages were infected with Y.
pseudotuberculosis ectopically expressing YopP to determine if the
enhanced cell death caused by this isoform is correlated with
higher caspase-1 activation and IL-1b secretion. Macrophages
were also infected with Y. pseudotuberculosis expressing catalytically
Figure 3. Caspase-8 activity is dispensable for KIM5-triggered macrophage death and IL-1b secretion. BMDMs were treated with 40 mM
caspase-8 inhibitor Z-IETD (IETD) or vehicle 1 hr prior to infection. The BMDMs were then infected with Y. pestis strains expressing YopJ
KIM or
YopJ
C172A or left uninfected (U). Infected cells were maintained in the presence of Z-IETD or the vehicle for the remainder of the experiment. At 8 hr
or 24 hr post-infection, supernatants were collected and LDH release (A) and IL-1b (B) were measured. Results shown are averages from three
independent experiments. Error bars represent standard deviations. w,P ,0.05 as determined by one way ANOVA compared to the YopJ
KIM infection
without inhibitor condition. (C) BMDMs were treated with 5 mM of MG-132 in the presence or absence of 40 mM Z-IETD for 30 min, followed by 1 mg/
ml of LPS for 3 hrs. Representative phase images of the treated BMDMs were captured by digital photomicroscopy.
doi:10.1371/journal.pone.0036019.g003
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C172A), the native isoform YopJ
YPTB,o r
YopJ
KIM. The different isoforms were expressed from a low copy
plasmid (pACYC184) in a Y. pseudotuberculosis DyopJ mutant (IP26).
Higher cytotoxicity and IL-1b release was detected in macro-
phages infected with Y. pseudotuberculosis expressing YopP as
compared to the other isoforms or the control strain with the
empty vector (Figure 10A and B). In ranking the different isoforms
YopP had the highest cytotoxicity, YopJ
YPTB the lowest killing
effect, and YopJ




Caspase-1 is not required for innate host protection
against Yersinia endowed with enhanced cytotoxicity
Y. pseudotuberculosis or Y. pestis strains ectopically expressing YopP
are attenuated in orogastric [47] or bubonic [49] models of mouse
infection, respectively. The basis for attenuation of Yersinia strains
endowed with enhanced cytotoxicity is not known, but it appears
to result from an increased innate immune response and does not
require CD8 T cell activation [47,49]. To determine if activation
of caspase-1 is important for the increased innate immune
response to Yersinia endowed with enhanced cytotoxicity,
Casp1
+/+ or Casp1
2/2 C57BL/6 mice were orogastrically
infected with Y. pseudotuberculosis ectopically expressing YopP.
Control mice were infected with Y. pseudotuberculosis ectopically
expressing YopJ
YPTB. Mouse survival was recorded over 21 days.
As shown previously [47] more Casp1
+/+ mice infected with the
YopP-expressing strain survived as compared to mice infected with
YopJ
YPTB-expressing bacteria (Figure 11A). However, Casp1
2/2
mice also showed enhanced survival following challenge with
YopP-expressing Y. pseudotuberculosis, indicating that caspase-1 is
dispensable for the increased innate immune response to Yersinia
with enhanced cytotoxicity. When the results were grouped
according to the infecting strain while ignoring mouse genotype
(Figure 11B), the survival of mice infected with Y. pseudotuberculosis
expressing YopP was significantly higher than the mice infected
with bacteria expressing YopJ
YPTB (P,0.01).
Discussion
Many pathogens activate inflammasomes/caspase-1 in macro-
phages, underscoring the general importance of this pathway for
host sensing of PAMPs and DAMPs and activating innate immune
responses [58]. We, and others, have been investigating different
mechanisms of inflammasome/caspase-1 activation in macro-
phages infected with pathogenic Yersinia species
[32,33,34,35,36,37]. Yersinia-mediated caspase-1 activation in
macrophages can occur by several different mechanisms. Insertion
of T3SS translocation channels or pores in the macrophage cell
plasma membrane appear to activate caspase-1 and cause
pyroptosis [33,34,36]. Priming of macrophages with LPS followed
by Yersinia infection can redirect apoptosis to pyroptosis [37]. In
both of the aforementioned cases YopJ is not required for
activation of caspase-1. A third mechanism of caspase-1 activation
that occurs in naive macrophages infected with Yersinia requires
YopJ catalytic activity [32,35,36].
YopJ inhibits NF-kB and MAPK pathways that activate
transcription of cell survival genes, promoting macrophage cell
death in response to apoptotic signaling from TLR4 [43,59]. In
addition, suppression of the NF-kB pathway by YopJ [32] or
genetic or pharmacological inhibition of IKKb [60] triggers
TLR4-dependent activation of caspase-1. The conditions used for
infection of macrophages with Yersinia affect the outcome of YopJ-
mediated caspase-1 activation. Incubation of macrophages with Y.
pseudotuberculosis under conditions of high MOI (20) and extended
contact with extracellular bacteria (1 hr) results in rapid activation
of caspase-1 but IL-1b release is undetectable and caspase-1
activation does not depend on NLRP3 nor ASC [36]. Infection of
macrophages with Y. pestis KIM5 under low MOI (10) and short
contact time (20 min) results in delayed caspase-1 activation, high
level of IL-1b release and cytotoxicity in a YopJ dependent
manner [32,35]. In addition, NLRP3 and ASC are important for
IL-1b release from macrophages infected with KIM5 under the
low MOI procedure [32]. As an outcome of YopJ blocking the
NF-kB pathway, less pro-IL-1b would be synthesized in
macrophages, but processing of even a small pool of pro-IL-1b
by active caspase-1 can lead to detectable released IL-1b. In the
low MOI infection conditions used here, it is likely that low
amounts of YopJ are injected into macrophages, resulting in a
Figure 4. KIM5-infected macrophages have necrotic morphology as shown by Annexin V staining and PI uptake assay. BMDMs were
seeded on glass coverslips in a 24-well plate and infected with Y. pestis strains expressing YopJ
KIM or YopJ
C172A or left uninfected (U). Annexin V
staining and PI uptake assay was performed at 4 hr, 8 hr or 12 hr post-infection. Representative images were captured by digital photomicroscopy.
Average percentages of Annexin V positive or Annexin V/PI double positive cells as counted from three random fields in three independent
experiments are shown. Error bars represent standard deviations. Difference in values of single or double positive cells were not significant as
determined by one way ANOVA.
doi:10.1371/journal.pone.0036019.g004
Figure 5. HMGB1 is released from KIM5-infected macrophages.
BMDMs were infected with Y. pestis strains expressing YopJ
KIM or
YopJ
C172A or left uninfected (U). Medium from infected macrophages
was collected at 24 hr post infection and immunoblotted for HMGB1.
Total cell lysate (Lys) was used as a positive control. Position of
molecular weight standard (kDa) is shown on the left.
doi:10.1371/journal.pone.0036019.g005
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infection condition may allow macrophages sufficient time to
synthesize pro-IL-1b before cell death occurs.
To investigate the mechanism of YopJ
KIM-induced caspase-1
activation and its connection to cell death in macrophages, we first
investigated the importance of apoptosis. The low caspase-3/7
activity (Figure 1) and the dispensable role for caspase-8 (Figure 3)
in cell death are consistent with the idea that apoptosis is not
strongly activated in KIM5-infected macrophages under our
experimental conditions. A previous study in which KIM5 was
used to infect macrophages reported relatively high levels of
caspase-3/7 and caspase-8 activity [61]. Spinner et al [61] used
murine J774A.1 cells as well as an MOI of 50, which could explain
why higher caspase activity was detected as compared to our
results. Additional evidence for caspase-8 activation in Yersinia-
infected macrophages comes from Bid cleavage assays. Caspase-8
cleavage has been detected in Yersinia infected dendritic cells and in
macrophages treated with LPS/MG-132 to activate apoptosis
[45,52,59]. Caspase-8 has been reported to process pro-IL-1b after
stimulation of TLR3/TLR4 signaling in macrophages [62], but in
our studies a caspase-8 inhibitor did not decrease IL-1b release in
KIM5-infected macrophages (Figure 3). Participation of mito-
chondrial-induced apoptosis in death of macrophages infected
with Y. enterocolitica has been implicated by the observed release of
cytochrome c [45]. However, YopP-induced cell death in dendritic
cells was not inhibited by overexpression of Bcl-2 [50]. In our
studies the use of Bax/Bak knockout BMDMs would mimic Bcl-2
over-expression by preventing pore formation on the mitochon-
drial membrane, however loss of Bax and Bak did not decrease cell
death or IL-1b secretion in KIM5-infected infected macrophages
(Figure 2).
Necrosis releases inflammatory cell contents, which is consistent
with proinflammatory cytokine production in KIM5-infected
macrophages [35]. Annexin V/PI staining was performed to
observe macrophage plasma membrane integrity over time.
Annexin V single positive cells representing the early apoptosis
population occurred in parallel with Annexin V/PI double positive
cells representing the late apoptosis or necrosis population
(Figure 4). The presence of the two populations indicates that
apoptosis and necrosis may coincide. However, cells with the
double positive phenotype may not arise from necrosis, especially
in cell culture when apoptotic cells are not engulfed by bystander
phagocytes, but rather from ‘‘secondary necrosis’’ [10]. Thus, to
be sure that KIM5-infected macrophages are dying of necrosis,
accumulation of more evidence is needed.
HMGB1 release is a very distinctive marker of necrosis [54].
The observed release of HMGB1 from KIM5-infected macro-
phages (Figure 5) strongly suggests that these cells are dying of
necrosis. Although HMGB1 can be passively secreted by activated
dendritic cells and macrophages [63], infection of macrophages
with Y. pestis expressing YopJ
C172A, which would activate
macrophages through LPS-TLR4 signaling, did not result in
HMGB1 release (Figure 5). To determine if released HMGB1
could be important for cell death and activation of caspase-1,
medium from KIM5-infected macrophages was transferred to
naive uninfected macrophages. However, the conditioned medium
Figure 6. KIM5-infected necrotic macrophages contain active caspase-1. BMDMs were seeded on glass coverslips in a 24-well plate and left
uninfected (U) or infected with Y. pestis strains expressing YopJ
KIM or YopJ
C172A. FAM-YVAD-FMK was added at 9 hr post infection to stain for active
caspase-1 and PI uptake assay was performed immediately before microscopic analysis. (A) Representative images of phase, active caspase-1 (green)
and PI uptake (red) signals captured by digital photomicroscopy are shown in a-c and e-g, respectively. Panels d and h show merged images of green
and red signals. (B) Average percentages of BMDMs positive for active caspase-1, PI or both signals was calculated (,100–300 cells per field) from
three random fields in three independent experiments. Error bars represent standard deviations.
doi:10.1371/journal.pone.0036019.g006
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macrophages (Figure S1). Although HMGB1 has been shown to
stimulate pro-inflammatory cytokine production [64,65,66], it is
unlikely that HMGB1 interacts with TLR4 to promote IL-1b
production and cell death in our system.
Since necrotic cells release inflammatory cytokines and KIM5-
infected macrophages showed necrotic properties (Figure 4 and 5),
we performed caspase-1/PI staining to see if caspase-1 activation
takes place in necrotic cells (Figure 6). The highly overlapped
caspase-1/PI positive cell population supports the idea that these
two events occur in same cells. However, it is difficult to
discriminate if necrosis occurs earlier than caspase-1 activation.
The results of previous LDH and IL-1b time course release assays
showed LDH release 4 hr ahead of IL-1b secretion, suggesting
that cell death may happen earlier than caspase-1 activation [35].
As macrophages infected with KIM5 seem to die by necrosis,
and cell death initiated earlier than IL-1b release [35], we
hypothesized that necrosis could activate the inflammasome/
caspase-1. We tried to blocked necrosis through use of the RIP1
inhibitor necrostatin-1. RIP1 has been identified as an important
mediator of non-apoptotic death in many cell types. When
caspase-8 activity is inhibited, preventing cleavage of RIP1, RIP1
positively activates a necrotic (necroptosis) pathway [67]. Cell
death triggered with Fas ligand (FasL) or tumor necrosis factor-a
(TNF-a) through caspase-8 activation, combined with pan-caspase
or caspase-8 inhibitor treatment, is RIP1 dependent and could be
prevented by specific RIP1 inhibitor necrostatin-1 [68,69,70]. In
macrophages after TLR4 stimulation, when the cell NF-kB
survival signaling pathway and caspase-8 activation are inhibited,
RIP1 causes necrosis [71,72,73]. RIP1 has also been implicated in
death of dendritic cells infected with Y. enterocolitica O:8 strain WA-
314, and the same group obtained evidence that dendritic cells
could die by necrosis in the same infection conditions [50,52].
However, in our infection model, the RIP1 specific inhibitor
necrostatin-1 did not reduce cell death (Figure 7). Treatment with
necrostatin did inhibit IL-1b release at 8 hours post infection
(Figure 7), which may due to lack of interaction between RIP1 and
the NF-kB pathway [71]. RIP3 has also been implicated in
necrosis, and although it is not clear if RIP3 and RIP1 can form a
heterodimer, RIP3 alone could induce necrosis [74,75,76]. It
Figure 7. RIP1 is not required for YopJ
KIM-induced cell death or IL-1b secretion. BMDMs were treated with 30 mM RIP1 inhibitor necrostatin-
1 (Nec) or vehicle 1 hr prior to and during infection. BMDMs were infected with Y. pestis strains expressing YopJ
KIM or YopJ
C172A or left uninfected (U).
Supernatants were collected and LDH release (A) and secreted IL-1b (B) were measured at 8 hr or 24 hr post-infection from three independent
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to determine the role of this kinase in YopJ
KIM-induced cell death
and caspase-1 activation.
Two recent studies discovered that necrosis could activate the
inflammasome/caspase-1 [77,78]. In the study of Iyer et al.,
mitochondrial ATP release from necrotic cells activated NLRP3/
Figure 8. ROS are not required for cytotoxicity or IL-1b secretion in macrophages infected with KIM5. BMDMs were treated with 10 mM
of DPI or 10 mM of NAC for 2 hours or left untreated. (A and B) BMDMs were infected with Y. pestis strains expressing YopJ
KIM or YopJ
C172A or left
uninfected (U). Supernatants were collected at 8 hr and 24 hr post-infection and analyzed by IL-1b ELISA (A) or LDH release assay (B). (C and D)
BMDMs treated or not with DPI or NAC as above were exposed to 50 ng/ml of LPS for 3 hr. The treated BMDMs were then exposed to 5 mM ATP for
1 hr to activate pyroptosis. Supernatants were tested by IL-1b ELISA (C) or LDH release assay (D). Results shown are the averages from three
independent experiments. Error bars represent standard deviations (ww, P,0.01; www, P,0.001, determined by one way ANOVA as compared to
LPS+ATP no inhibitor).
doi:10.1371/journal.pone.0036019.g008
Caspase Activation in Yersinia-Infected Macrophage
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e36019caspase-1 in LPS primed macrophages through P2X7 receptor
[78]. This pathway does not occur in our model, since we have
shown that P2X7 receptor is not required for secretion of IL-1b in
KIM5-infected macrophages [32].
NLRP3 and ASC were important for secretion of IL-1b from
KIM5-infected macrophages, although these inflammasome
components were dispensable for cell death [32]. Consistent with
an important role for NLRP3 and ASC in caspase-1 activation was
the observation that exogenous K
+ inhibited secretion of IL-1b
from KIM5-infected macrophages. Specifically, extracellular K
+,
but not Na
+, down regulated IL-1b release in KIM5-infected
macrophages, suggesting that NLRP3 activation requires a low
concentration of intracellular K
+ [32]. Low intracellular K
+ levels
could result from intracellular K
+ passing through ATP-sensitive
K
+ channels (such as P2X7), or by its release from dying cells
[56,79]. As mentioned above P2X7 receptor is not required for IL-
1b release in KIM5-infected macrophages, suggesting that pore
formation in necrotic macrophages may allow K
+ efflux.
As NLRP3 can recognize ROS generation, or lysosome rupture
leading to caspase-1 activation, we tested each of these processes
for their importance in IL-1b secretion in KIM5-infected
macrophages. With respect to the ROS generation model, most
pathogens that activate caspase-1 through NLRP3 induce ROS
generation and in many cases, K
+ efflux occurs simultaneously
[56]. However, two ROS inhibitors, DPI and NAC, had no
significant effect on IL-1b release or cell death in KIM5-infected
macrophages (Figure 8). These inhibitors did reduce pyroptosis of
macrophages following LPS/ATP treatment (Figure 8C and 8D),
conditions that are known to produce high levels of ROS [80].
The lysosome rupture model was tested by the use of cathepsin
B inhibitors (Figure 9). Both inhibitors reduced IL-1b secretion
and caspase-1 activation in KIM5-infected macrophages. Halle et
Figure 9. Inhibitors of cathepsin B reduce caspase-1 activation in macrophages infected with KIM5. BMDMs were left untreated or
treated with 25 mM of E64d or CA-074 Me (CA) for 1 hr. Following infection with Y. pestis strains expressing YopJ
KIM in the absence or presence of the
inhibitors, supernatants were collected (A, B) or microscopic assay was performed (C). IL-1b ELISA (A) and LDH release assay (B) was done on
supernatants collected 24 hr post-infection. Results shown are the averages from three independent experiments. Error bars represent standard
deviations. (ww, P,0.01 as determined by one way ANOVA as compared to infection in absence of inhibitor) (C) Infected BMDMs on coverslips were
incubated with FAM-YVAD-FAM 9 hr post-infection stained for active caspase-1 (green) for 1 hr and PI uptake (red) immediately before observation.
Representative images of phase, green and red signals were captured by digital photomicroscopy.
doi:10.1371/journal.pone.0036019.g009
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phagocytosis of amyloid-beta and showed reduced secretion of IL-
1b in cathepsin B knockout macrophages as well as in cathepsin B
inhibitor-treated wild type cells [81]. However, off target effects of
the inhibitors on caspase-1 activation in KIM5-infected macro-
phages cannot be ruled out. We could show that the inhibitors
reduced IL-1b secretion but not cell death in S. Typhimurium
infected macrophages undergoing pyroptosis (Figure S2). There-
fore, cathepsin B may be specifically required for activation of
inflammasomes that are dedicated to processing of pro-IL-1b [19].
In Brodsky et al. [47], Y. pseudotuberculosis ectopically expressing
YopP was more attenuated than the same strain expressing
YopJ
YPTB in a mouse oral infection model. The authors suggested
that the hypercytotoxic strain eliminated infected macrophages
that served as a niche for Yersinia survival in vivo [47]. Another
study showed that a Y. pestis strain ectopically expressing YopP was
attenuated in a mouse bubonic infection model [49]. In addition,
mice infected with the hypercytotoxic attenuated strain were
protected against concurrent challenge with fully virulent Y. pestis
[49]. We hypothesized that the highly cytotoxic YopP could
stimulate efficient caspase-1 activation in vivo leading to caspase-1-
based protection. In an in vitro macrophage infection, Y.
pseudotuberculosis expressing YopP, the same strain used in a
previous study [47] triggered high levels of secreted IL-1b and
cytotoxicity (Figure 10A and 10B). However, there was no
difference in survival for wild type and caspase-1 knockout mice
infected with the hyercytotoxic Y. pseudotuberculosis strain
(Figure 11). Thus, it seems that caspase-1 does not protect mice
from oral infection with Yersinia strains with enhanced cytotoxicity.
Zauberman et al. showed that increased protection of mice against
a hypercytotoxic Y. pestis strain was seen in subcutaneous
challenge, but not in intranasal or intravenous infection, revealing
that infection route is important [49]. Our findings do not rule out
the possibility that caspase-1 activation is important for protection
of mice against subcutaneous infection with a hypercytotoxic Y.
pestis. In addition, caspase-1-mediated protection of mice against
oral challenge with a hypercytotoxic strain may not be measurable
using a survival assay, but could significantly impact organ
burdens and serum cytokine levels.
In summary, in this paper, we studied the mechanism of
caspase-1 and cell death mediated by YopJ
KIM and tried to find
the relationship between them. Our results indicate that
macrophages died by necrosis rather than apoptosis. Caspase-1
activation through the NLRP3/ASC inflammasome may result
from K
+ efflux and lysosome rupture that occur during necrosis.
Furthermore, most of the active caspase-1 is located in necrotic
cells, and levels of secreted IL-1b could be positively correlated to
levels of YopJ/P cytotoxicity. According to the evidence, we
hypothesize that necrosis may activate caspase-1 in KIM5-infected
Figure 10. Enhanced YopP-mediated macrophage cell death is
associated with elevated levels of IL-1b release. Y. pseudotuber-
culosis IP26 (DyopJ) carrying the empty pACYC184 plasmid (pACYC) or
pACYC184 encoding the indicated YopP or YopJ isoforms was used to
infect BMDMs. Twenty four hours post-infection, medium was collected
for IL-1b ELISA (A) and LDH release assay (B). Results shown are the
averages from three independent experiments. Error bars represent
standard deviations (ww, P,0.01; www, P,0.001 as determined by
one way ANOVA as compared to pACYC condition).
doi:10.1371/journal.pone.0036019.g010
Figure 11. Caspase-1 is not required for innate host protection
against Yersinia endowed with enhanced cytotoxicity. (A) Six to
eight-week old Casp1
+/+ (wild type, WT) or Casp1
2/2 (Casp1-) C57BL/6J
mice were infected orogastrically with 1610
9 CFU of Y. pseudotubercu-
losis IP26 carrying pACYC184 encoding YopP or YopJ
YPTB. Mouse
survival was monitored for 21 days. Results shown are pooled from two
independent experiments. Total numbers of mice infected are shown in
parenthesis. (B) Data from (A) are reformatted by grouping mice
according to infecting strain. Significant difference between survival
curves was determined by log rank test.
doi:10.1371/journal.pone.0036019.g011
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All animal use procedures were conducted following the NIH
Guide for the Care and Use of Laboratory Animals and performed
in accordance with institutional regulations after review and
approval by the Institutional Animal Care and Use Committee at
Stony Brook University.
Bacterial strains and growth conditions
The Y. pestis strains used in this study, KIM5 and KIM5
expressing YopJ
C172A, lack the chromosomal pigmentation locus
(pgm) and are exempt from select agent guidelines [35]. The
pACYC184 plasmids encoding Y. enterocolitica 8081 YopP or Y.
pseudotuberculosis IP2666 YopJ (termed as YopJ
YPTB) were a kind
gift of Dr. Igor Brodsky [47]. Condon changes were introduced
into the plasmid encoding YopJ
YPTB to yield YopJ
KIM (F177L) or
into the plasmid encoding YopP to yield YopP
C172A (C172A) using
Quikchange (Invitrogen). Y. pseudotuberculosis strain IP2666DyopJ
(termed as IP26) [35] was transformed with pACYC184 or
pACYC184 plasmids encoding the different YopP or YopJ
isoforms. Plasmid transformation of IP26 was achieved by
electroporation, followed by selection on Luria Broth (LB) plates
containing chloramphenicol (30 mg/ml) [35]. Cultures of Y. pestis
and Y. pseudotuberculosis for macrophage infection were prepared as
described [35].
S. Typhimurium SL1344 culture was prepared as described
[82]. Briefly, overnight culture was diluted 1:15 in LB supple-
mented with 0.3M NaCl and grown at 37uC for 3 hr without
shaking.
BMDM isolation and culture conditions
BMDMs were isolated from bone marrow taken from femurs of
6- to 8-week old C57BL/6J female mice (Jackson Laboratories) as
previously described [83]. Frozen stocks of bone marrow cells from





+/2) [84] (obtained from Tullia Lindsten,
University of Pennsylvania and Craig Roy, Yale University) were
propagated in DMEM GlutaMax supplemented with 20% fetal
bovine serum, 30% L-cell-conditioned medium and 1% 0.1 M
sodium pyruvate (BMM-high) to obtain BMDM.
Macrophage infection
Twenty-four hours before infection, BMDMs were seeded in
24-well plates at a density of 1.5610
5 cells/well in DMEM
GlutaMax supplemented with 10% fetal bovine serum, 15% L-
cell-conditioned medium and 1% 0.1 M sodium pyruvate (BMM-
low). The next day, macrophages were infected with Yersinia at a
MOI of 10 as described [35]. For SL1344 infection, cells were
infected at an MOI of 10 without a centrifugation step.
Gentamicin (15 mg/ml) was added 2 hr post infection, and culture
medium was collected following a 2 hr incubation. In some
experiments, cells were treated with 10 mM of NAC (Sigma), or
10 mM of DPI (Sigma) for 2 hr before infection. In other
experiments the BMDMs were treated with 30 mM of necrosta-
tin-1 (Biomol), 25 mM of CA-074 Me (Biomol), 40 mM of IETD-
CHO (Calbiochem) or 25 mM of E64d (Biomol) for 1 hr before
infection and during the remainder of the infection period. For the
caspase-8 inhibitor positive control experiment, cells were
pretreated with 5 mM of MG-132 (Sigma) for 30 min with or
without 40 mM of IETD-CHO and then incubated with 1 mg/ml
of LPS for 3 hours.
Microscopic assay to detect surface staining with annexin
V and PI uptake
BMDMs were plated on glass coverslips in 24-well plates and
infected as described above. At 4, 8 and 12 hr post infection,
Annexin V and PI were diluted in Hank’s balanced salt solution
(HBSS) according to manufacturer’s protocol (Roche) and added
to the cells. After 15 minutes of staining, the reagents were
removed and cells were washed with phosphate buffered saline
(PBS). Cells were maintained in PBS and visualized by
fluorescence microscopy using a Zeiss Axiovert S100 microscope
equipped with a 406objective. Images were captured using a Spot
camera (Diagnostic Instruments, Inc.) and processed by Adobe
Photoshop 7.0. Quantification of percent caspase-1 positive
BMDMs was performed by scoring macrophages for positive
signal in three different randomly selected fields (,70–130 cells
per field) on a coverslip.
Microscopic assay to detect PI uptake and active
caspase-1
BMDMs were plated on glass coverslips in 24-well plates and
infected as described above. Nine hours post-infection, macro-
phages were stained with 6-carboxyfluorescein–YVAD– fluoro-
methylketone (FAM-YVAD-FMK; Immunochemistry Technolo-
gies) as described before [35] and 1 mg/ml PI immediately before
observation. Cells were maintained in PBS and visualized by phase
and fluorescence microscopy. Images were captured and processed
as mentioned above. Quantification of caspase-1 positive or PI
positive cell percentages was performed by counting for positive
cells in randomly selected fields (,100–300 cells/field) from three
independent experiments.
Caspase-3/7 luminol assay
Caspase 3/7 activity was measured by Caspase-Glo 3/7 Assay
Kit (Promega) according to manufacturer’s instruction. BMDMs
were seeded in a 96-well white-walled plate at a concentration of
10
4cells/well in 100 ul medium. Infection was performed as
described above. At each time point, a 100 ul of detection buffer
was added to a well and the plate was read using a luminescence
reader (SpectraMax M2, Molecular Devices).
Immunoblot analysis
For detection of HMGB1 and PARP by immunoblotting,
macrophages were infected as above except that BMDMs were
seeded in 6-well plates at a concentration of 10
6cells/well. Infected
cells were maintained in 1 ml of culture medium per well
supplemented with 4.5 mg/ml of gentamicin for 24 hours. For
detection of HMGB1, harvested culture medium was centrifuged,
the supernatant mixed with the same volume of 26Laemmli
buffer, and boiled samples were resolved by SDS-PAGE (15%
gels). BMDMs were lysed in 16Laemmli buffer to obtain a sample
of lysate for use as a positive control. Cell lysates for PARP
immunoblotting were prepared by removing the media overlaying
BMDM monolayers and adding 16Laemmli buffer into the wells.
Boiled lysate samples were resolved SDS-PAGE (8% gels).
Uninfected BMDMs were treated with staurosporine (1 mM,
Biomol) 16 hours before lysis to provide a control for cleaved
PARP. Proteins were transferred from gels to polyvinylidene
fluoride (PVDF) membranes and the membranes were probed
sequentially with rabbit anti-HMGB1 (Abcam) or anti-PARP
(Santa Cruz) primary antibodies, and goat anti-rabbit HRP
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detected with enhanced chemiluminescence reagents (Perkin
Elmer Life Sciences, Inc.).
IL-1b ELISA
IL-1b was measured from supernatants by ELISA [35]
according to manufacturer’s instructions (R&D).
LDH Release
Cell death was determined by CytoTox-96 nonradioactive
cytotoxicity assay (Promega) from supernatants following manu-
facturer’s instructions. The total LDH release was made by
freezing and thaw untreated cells. The percentage of dead cells




2/2) mice on the C57BL/6 back-
ground [85] were obtained from Richard Flavell and Craig Roy,
Yale University. The Casp1
2/2 mice upon receipt had been
backcrossed to C57BL/6 mice for 7 generations. The Casp1
2/2
mice were backcrossed to C57BL/6J mice (Jackson Laboratories)
for an additional three generations. The offspring were mated to
generate colonies of Casp1
2/2 or Casp1
+/+ mice that were used
for infection at 8–10 weeks of age. Y. pseudotuberculosis cultures were
grown overnight with shaking in LB at 26uC. Bacteria were
harvested by centrifugation and resuspended in PBS. Male and
female mice were fasted for 14–16 hr prior to infection. Infection
was achieved orogastrically with 1610
9 colony forming units of
bacteria in 0.2 ml of HBSS using a 20-gauge feeding needle. Mice
were monitored three times a day for 21 days. Mice displaying
severe signs of disease and deemed unable to survive were
euthanized by CO2 asphyxiation.
Statistical analysis
Statistical analysis was performed with Prism 4.0 (Graphpad)
software. The tests used are as indicated in the figure legends or
main text. P values of less than 0.05 were considered significant.
Supporting Information
Figure S1 Transfer of media from KIM5-infected macrophages
to uninfected macrophages does not lead to increased cell death or
IL-1b release. BMDMs in 6-well plates with 3 ml of medium per
well were infected with Y. pestis expressing YopJ
KIM or YopJ
C712A
or left infected (U). Twenty four hours post-infection, supernatants
(1 ml) were collected and transferred into wells of a 24 well dish
containing uninfected BMDMs or empty wells as background (B)
control. Supernatants were collected after an addition 24 hours.
IL-1b and LDH were measured by ELISA (panel A) or
CytoTox96 assay (panel B), respectively. Results are averaged
from three independent experiments and error bars represent
standard deviations.
(TIF)
Figure S2 Cathepsin B inhibitors reduced IL-1b release, but not
cell death in macrophages infected with S. Typhimurium SL1344.
BMDMs were left untreated or pretreated with 25 mM of E64d or
CA-074 Me (CA) for 1 hr. Untreated BMDMs were left
uninfected (U) or infected with SL1344 at an MOI of 10 for
4 hours. Treated BMDMs were infected with SL1344 under the
same conditions in the presence of the inhibitors. Medium was
collected for IL-1b ELISA (A) and LDH release assays (B). Results




We thank Tullia Lindsten, University of Pennsylvania and Craig Roy, Yale





+/2 mice. We would also like to thank Craig Royand Richard Flavell for
Casp1
2/2 mice, Igor Brodsky for the gift of pACYC-YopP/J plasmids, and
Galina Romanov for isolation and propagation of murine macrophages.
Author Contributions
Conceived and designed the experiments: YZ SL JB. Performed the
experiments: YZ SL PM. Analyzed the data: YZ JB. Wrote the paper: YZ
JB.
References
1. Dockrell DH (2001) Apoptotic cell death in the pathogenesis of infectious
diseases. J Infect 42: 227–234.
2. Fairbairn IP (2004) Macrophage apoptosis in host immunity to mycobacterial
infections. Biochem Soc Trans 32: 496–498.
3. Jonas D, Walev I, Berger T, Liebetrau M, Palmer M, et al. (1994) Novel path to
apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in
T lymphocytes evoke internucleosomal DNA degradation. Infect Immun 62:
1304–1312.
4. Navarre WW, Zychlinsky A (2000) Pathogen-induced apoptosis of macrophages:
a common end for different pathogenic strategies. Cell Microbiol 2: 265–273.
5. Porcelli SA, Jacobs WR, Jr. (2008) Tuberculosis: unsealing the apoptotic
envelope. Nat Immunol 9: 1101–1102.
6. Winau F, Weber S, Sad S, de Diego J, Hoops SL, et al. (2006) Apoptotic vesicles
crossprime CD8 T cells and protect against tuberculosis. Immunity 24: 105–117.
7. Zhang Y, Ting AT, Marcu KB, Bliska JB (2005) Inhibition of MAPK and NF-
kappa B pathways is necessary for rapid apoptosis in macrophages infected with
Yersinia. J Immunol 174: 7939–7949.
8. Monack DM, Mecsas J, Ghori N, Falkow S (1997) Yersinia signals macrophages
to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad
Sci USA 94: 10385–10390.
9. Fink SL, Cookson BT (2005) Apoptosis, pyroptosis, and necrosis: mechanistic
description of dead and dying eukaryotic cells. Infect Immun 73: 1907–1916.
10. Zong WX, Thompson CB (2006) Necrotic death as a cell fate. Genes Dev 20:
1–15.
11. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:
2095–2147.
12. Dinarello CA (1999) IL-18: A TH1-inducing, proinflammatory cytokine and
new member of the IL-1 family. J Allergy Clin Immunol 103: 11–24.
13. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, et al. (2007)
Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1
activation. Mol Cell 25: 713–724.
14. Amer A, Franchi L, Kanneganti TD, Body-Malapel M, Ozoren N, et al. (2006)
Regulation of Legionella phagosome maturation and infection through flagellin
and host Ipaf. J Biol Chem 281: 35217–35223.
15. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, et al. (2006)
Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta
in salmonella-infected macrophages. Nat Immunol 7: 576–582.
16. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, et al. (2006)
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature
440: 228–232.
17. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS,
et al. (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive
immunity through its regulation of caspase-1. Immunity 24: 317–327.
18. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140: 821–832.
19. Broz P, von Moltke J, Jones JW, Vance RE, Monack DM (2010) Differential
requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and
cytokine processing. Cell Host Microbe 8: 471–483.
20. Case CL, Shin S, Roy CR (2009) Asc and Ipaf Inflammasomes direct distinct
pathways for caspase-1 activation in response to Legionella pneumophila. Infect
Immun 77: 1981–1991.
21. Fink SL, Cookson BT (2006) Caspase-1-dependent pore formation during
pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 8:
1812–1825.
22. Hilbi H, Moss JE, Hersh D, Chen Y, Arondel J, et al. (1998) Shigella-induced
apoptosis is dependent on caspase-1 which binds to IpaB. J Biol Chem 273:
32895–32900.
Caspase Activation in Yersinia-Infected Macrophage
PLoS ONE | www.plosone.org 13 April 2012 | Volume 7 | Issue 4 | e3601923. Mariathasan S, Weiss DS, Dixit VM, Monack DM (2005) Innate immunity
against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp
Med 202: 1043–1049.
24. Hentze H, Lin XY, Choi MS, Porter AG (2003) Critical role for cathepsin B in
mediating caspase-1-dependent interleukin-18 maturation and caspase-1-
independent necrosis triggered by the microbial toxin nigericin. Cell Death
Differ 10: 956–968.
25. Willingham SB, Bergstralh DT, O’Connor W, Morrison AC, Taxman DJ, et al.
(2007) Microbial pathogen-induced necrotic cell death mediated by the
inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host
Microbe 2: 147–159.
26. Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, et al. (2002) De
novo CIAS1 mutations, cytokine activation, and evidence for genetic
heterogeneity in patients with neonatal-onset multisystem inflammatory disease
(NOMID): a new member of the expanding family of pyrin-associated
autoinflammatory diseases. Arthritis Rheum 46: 3340–3348.
27. Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, et al. (2002) Chronic
infantile neurological cutaneous and articular syndrome is caused by mutations
in CIAS1, a gene highly expressed in polymorphonuclear cells and chondro-
cytes. Am J Hum Genet 71: 198–203.
28. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001)
Mutation of a new gene encoding a putative pyrin-like protein causes familial
cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29:
301–305.
29. Duncan JA, Gao X, Huang MT, O’Connor BP, Thomas CE, et al. (2009)
Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the
signaling activities of the NLRP3 and ASC-containing inflammasome.
J Immunol 182: 6460–6469.
30. Ting JP, Willingham SB, Bergstralh DT (2008) NLRs at the intersection of cell
death and immunity. Nat Rev Immunol 8: 372–379.
31. Viboud GI, Bliska JB (2005) Yersinia outer proteins: role in modulation of host
cell signaling responses and pathogenesis. Annu Rev Microbiol 59: 69–89.
32. Zheng Y, Lilo S, Brodsky IE, Zhang Y, Medzhitov R, et al. (2011) A Yersinia
effector with enhanced inhibitory activity on the NF-kappaB pathway activates
the NLRP3/ASC/caspase-1 inflammasome in macrophages. PLoS Pathog 7:
e1002026.
33. Shin H, Cornelis GR (2007) Type III secretion translocation pores of Yersinia
enterocolitica trigger maturation and release of pro-inflammatory IL-1beta. Cell
Microbiol 9: 2893–2902.
34. Schotte P, Denecker G, Van Den Broeke A, Vandenabeele P, Cornelis GR,
et al. (2004) Targeting Rac1 by the Yersinia effector protein YopE inhibits
caspase-1-mediated maturation and release of interleukin-1beta. J Biol Chem
279: 25134–25142.
35. Lilo S, Zheng Y, Bliska JB (2008) Caspase-1 activation in macrophages infected
with Yersinia pestis KIM requires the type III secretion system effector YopJ.
Infect Immun.
36. Brodsky IE, Palm NW, Sadanand S, Ryndak MB, Sutterwala FS, et al. (2010) A
Yersinia effector protein promotes virulence by preventing inflammasome
recognition of the type III secretion system. Cell Host Microbe 7: 376–387.
37. Bergsbaken T, Cookson BT (2007) Macrophage activation redirects yersinia-
infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS
Pathog 3: e161.
38. Mittal R, Peak-Chew SY, McMahon HT (2006) Acetylation of MEK2 and I
kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc
Natl Acad Sci U S A 103: 18574–18579.
39. Mukherjee S, Hao YH, Orth K (2007) A newly discovered post-translational
modification–the acetylation of serine and threonine residues. Trends Biochem
Sci 32: 210–216.
40. Mittal R, Peak-Chew SY, Sade RS, Vallis Y, McMahon HT (2010) The
acetyltransferase activity of the bacterial toxin YopJ of Yersinia is activated by
eukaryotic host cell inositol hexakisphosphate. J Biol Chem 285: 19927–19934.
41. Ruckdeschel K, Mannel O, Schrottner P (2002) Divergence of apoptosis-
inducing and preventing signals in bacteria-faced macrophages through myeloid
differentiation factor 88 and IL-1 receptor-associated kinase members.
J Immunol 168: 4601–4611.
42. Orth K (2002) Function of the Yersinia effector YopJ. Curr Opin Microbiol 5:
38–43.
43. Zhang Y, Bliska JB (2003) Role of Toll-like receptor signaling in the apoptotic
response of macrophages to Yersinia infection. Infect Immun 71: 1513–1519.
44. Haase R, Kirschning CJ, Sing A, Schrottner P, Fukase K, et al. (2003) A
dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-
faced macrophages. J Immunol 171: 4294–4303.
45. Denecker G, Declercq W, Geuijen CA, Boland A, Benabdillah R, et al. (2001)
Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the
apoptotic signaling cascade upstream of bid. J Biol Chem 276: 19706–19714.
46. Ruckdeschel K, Richter K, Mannel O, Heesemann J (2001) Arginine-143 of
Yersinia enterocolitica YopP crucially determines isotype-related NF-kappaB
suppression and apoptosis induction in macrophages. Infect Immun 69:
7652–7662.
47. Brodsky IE, Medzhitov R (2008) Reduced secretion of YopJ by Yersinia limits in
vivo cell death but enhances bacterial virulence. PLoS Pathog 4: e1000067.
48. Zauberman A, Cohen S, Mamroud E, Flashner Y, Tidhar A, et al. (2006)
Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent
apoptosis. Infect Immun 74: 3239–3250.
49. Zauberman A, Tidhar A, Levy Y, Bar-Haim E, Halperin G, et al. (2009)
Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic
plague model and induces rapid protection against pneumonic plague. PLoS
ONE 4: e5938.
50. Grobner S, Autenrieth SE, Soldanova I, Gunst DS, Schaller M, et al. (2006)
Yersinia YopP-induced apoptotic cell death in murine dendritic cells is partially
independent from action of caspases and exhibits necrosis-like features.
Apoptosis 11: 1959–1968.
51. Das R, Dhokalia A, Huang XZ, Hammamieh R, Chakraborty N, et al. (2007)
Study of proinflammatory responses induced by Yersinia pestis in human
monocytes using cDNA arrays. Genes Immun 8: 308–319.
52. Grobner S, Adkins I, Schulz S, Richter K, Borgmann S, et al. (2007)
Catalytically active Yersinia outer protein P induces cleavage of RIP and
caspase-8 at the level of the DISC independently of death receptors in dendritic
cells. Apoptosis 12: 1813–1825.
53. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, et al. (2001)
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction
and death. Science 292: 727–730.
54. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1
by necrotic cells triggers inflammation. Nature 418: 191–195.
55. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, et al. (2005) Chemical inhibitor
of nonapoptotic cell death with therapeutic potential for ischemic brain injury.
Nat Chem Biol 1: 112–119.
56. Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: The
convergence of multiple signalling pathways on ROS production? Nat Rev
Immunol 10: 210–215.
57. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. (2008) Silica
crystals and aluminum salts activate the NALP3 inflammasome through
phagosomal destabilization. Nat Immunol 9: 847–856.
58. Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: host cell death and
inflammation. Nat Rev Microbiol 7: 99–109.
59. Ruckdeschel K, Pfaffinger G, Haase R, Sing A, Weighardt H, et al. (2004)
Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor
domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-
infected murine macrophages. J Immunol 173: 3320–3328.
60. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, et al. (2007) NF-kappaB is
a negative regulator of IL-1beta secretion as revealed by genetic and
pharmacological inhibition of IKKbeta. Cell 130: 918–931.
61. Spinner JL, Seo KS, O’Loughlin JL, Cundiff JA, Minnich SA, et al. (2010)
Neutrophils are resistant to Yersinia YopJ/P-induced apoptosis and are
protected from ROS-mediated cell death by the type III secretion system.
PLoS ONE 5: e9279.
62. Maelfait J, Vercammen E, Janssens S, Schotte P, Haegman M, et al. (2008)
Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation
by caspase-8. J Exp Med 205: 1967–1973.
63. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, et al. (2003) Monocytic
cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.
EMBO J 22: 5551–5560.
64. Sha Y, Zmijewski J, Xu Z, Abraham E (2008) HMGB1 develops enhanced
proinflammatory activity by binding to cytokines. J Immunol 180: 2531–2537.
65. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A (2008) HMGB1:
endogenous danger signaling. Mol Med 14: 476–484.
66. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, et al. (2000)
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine
synthesis in human monocytes. J Exp Med 192: 565–570.
67. Lin Y, Devin A, Rodriguez Y, Liu ZG (1999) Cleavage of the death domain
kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13:
2514–2526.
68. Holler N, Zaru R, Micheau O, Thome M, Attinger A, et al. (2000) Fas triggers
an alternative, caspase-8-independent cell death pathway using the kinase RIP
as effector molecule. Nat Immunol 1: 489–495.
69. Zheng L, Bidere N, Staudt D, Cubre A, Orenstein J, et al. (2006) Competitive
control of independent programs of tumor necrosis factor receptor-induced cell
death by TRADD and RIP1. Mol Cell Biol 26: 3505–3513.
70. Degterev A, Hitomi J, Germscheid M, Ch’en IL, Korkina O, et al. (2008)
Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat
Chem Biol 4: 313–321.
71. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P (2007) RIP1, a
kinase on the crossroads of a cell’s decision to live or die. Cell Death Differ 14:
400–410.
72. Ma Y, Temkin V, Liu H, Pope RM (2005) NF-kappaB protects macrophages
from lipopolysaccharide-induced cell death: the role of caspase 8 and receptor-
interacting protein. J Biol Chem 280: 41827–41834.
73. Grobner S, Schulz S, Soldanova I, Gunst DS, Waibel M, et al. (2007) Absence of
Toll-like receptor 4 signaling results in delayed Yersinia enterocolitica YopP-
induced cell death of dendritic cells. Infect Immun 75: 512–517.
74. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, et al. (2009) RIP3, an energy
metabolism regulator that switches TNF-induced cell death from apoptosis to
necrosis. Science 325: 332–336.
75. Upton JW, Kaiser WJ, Mocarski ES (2010) Virus inhibition of RIP3-dependent
necrosis. Cell Host Microbe 7: 302–313.
76. Declercq W, Vanden Berghe T, Vandenabeele P (2009) RIP kinases at the
crossroads of cell death and survival. Cell 138: 229–232.
Caspase Activation in Yersinia-Infected Macrophage
PLoS ONE | www.plosone.org 14 April 2012 | Volume 7 | Issue 4 | e3601977. Li H, Ambade A, Re F (2009) Cutting edge: Necrosis activates the NLRP3
inflammasome. J Immunol 183: 1528–1532.
78. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, et al. (2009) Necrotic
cells trigger a sterile inflammatory response through the Nlrp3 inflammasome.
Proc Natl Acad Sci U S A 106: 20388–20393.
79. Bortner CD, Cidlowski JA (2002) Apoptotic volume decrease and the incredible
shrinking cell. Cell Death Differ 9: 1307–1310.
80. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, et al. (2007) ATP
activates a reactive oxygen species-dependent oxidative stress response and
secretion of proinflammatory cytokines in macrophages. J Biol Chem 282:
2871–2879.
81. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, et al. (2008) The
NALP3 inflammasome is involved in the innate immune response to amyloid-
beta. Nat Immunol 9: 857–865.
82. Brennan MA, Cookson BT (2000) Salmonella induces macrophage death by
caspase-1-dependent necrosis. Mol Microbiol 38: 31–40.
83. Pujol C, Bliska JB (2003) The ability to replicate in macrophages is conserved
between Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun 71:
5892–5899.
84. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, et al. (2000) The
combined functions of proapoptotic Bcl-2 family members bak and bax are
essential for normal development of multiple tissues. Mol Cell 6: 1389–1399.
85. Zamboni DS, Kobayashi KS, Kohlsdorf T, Ogura Y, Long EM, et al. (2006)
The Birc1e cytosolic pattern-recognition receptor contributes to the detection
and control of Legionella pneumophila infection. Nat Immunol 7: 318–325.
Caspase Activation in Yersinia-Infected Macrophage
PLoS ONE | www.plosone.org 15 April 2012 | Volume 7 | Issue 4 | e36019